226 top medical experts on Smith-Lemli-Opitz Syndrome across 29 countries and 25 U.S. states, including 72 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Smith-Lemli-Opitz Syndrome: An autosomal recessive disorder of cholesterol metabolism. It is caused by a deficiency of 7-dehydrocholesterol reductase, the enzyme that converts 7-dehydrocholesterol to cholesterol, leading to an abnormally low plasma cholesterol. This syndrome is characterized by multiple congenital abnormalities, growth deficiency, and intellectual disability.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Dyslipidemias (4,591), Inborn Errors Lipid Metabolism (797), Inborn Errors Steroid Metabolism (385), Multiple Abnormalities (3,208).
  4. Clinical Trials ClinicalTrials.gov : at least 14 including 1 Active, 6 Completed, 2 Recruiting


  

        

                    


    Computing Expert Listing ...

);